China Practice — Summary Engagements
For more than thirty years, the lawyers on Orrick’s China Team have been leading the successful completion of many prominent local and cross-border commercial and financial transactions involving China. Representative matters for primary areas of practice are included in the descriptions of each area of practice listed on the navigational side bar located on the left column of this page. A summary collection of representative matters covering all practice areas is available below or you may download a one-page list of Representative Matters in PDF format.
Securities
- Wumart Stores, Inc., in its IPO on the GEM of the HKEx and two secondary placements (total HK$1.25 billion). This was the largest IPO on the GEM in 2003.
- Weiqiao Textile Company Limited, in its HK$2.441 billion IPO on the Main Board of the HKEx.
- Shenzhou International Group Holdings Limited, in its HK$787.5 million IPO on the Main Board of the HKEx.
- Represented Sinopec Beijing Yanhua Petrochemical Company Ltd. as Hong Kong and U.S. Counsel in connection with the US$500 million privatization by its parent company, which involved the delisting of H shares and ADRs from the Main Board of the HKEx and the NYSE, respectively. This was the first privatization of an H share company in both Hong Kong and the U.S.
Private Equity, Venture Capital and Hedge Funds
- The HSBC Private Equity Fund 3 Ltd., a US$700 million closed-end fund for private equity investment in Asia, was organized as a Cayman Islands company with investors from the United States, Europe and Asia.
- ING Beijing Investment Company Limited, a closed-end fund for equity investments in China, was organized as a Hong Kong limited liability company and listed on the Hong Kong Stock Exchange.
Project Finance
- Advised General Motors Corporation and its partner in the structuring and execution of one of the largest project financings in China, consisting of a dual-currency, multiple-tranche US$1.52 billion project financing for the acquisition and construction of a Buick plant in Shanghai. At the time, the project represented the largest U.S. investment in China, the largest Sino-U.S. joint venture, the largest China project financed solely by commercial banks and the largest U.S. dollar and RMB syndication.
Corporate Finance
- Advised the world's third largest container leasing company in one of Asia's largest securitizations, a US$870 million transaction involving the sale of marine containers and the respective container lease agreements in more than 35 countries.
Real Estate
- Advised Shenzhen Yijing Central Walk Retail Development Company on the first partnership in Shenzhen involving a Chinese private enterprise and a foreign investment fund, for the continued development and operation of the Central Walk retail and entertainment center located underneath Shenzhen's newly planned Central City Park.
Mergers and Acquisitions
- Advised the vendor, Pfizer Inc., in the US$410 million sale of the China operations of its Schick Division to Energizer Holdings.
- Advised the acquirer, China National Chemicals Import and Export Corporation, on the US$105 million acquisition of a subsidiary of Norway’s Petroleum Geo-Services ASA.
- Advised the acquirer, SC Johnson Wax, in the US$733 million acquisition of Bayer’s household insecticides business with products in 46 countries.
- Advised a Hong Kong listed subsidiary of a large Chinese shipping company in the approximately US$1 billion acquisition of the world’s fifth-largest marine terminal operator, including facilities in eight countries.
- Advised Jarden Corporation, a consumer products company, in the US$240 million acquisition of the Holmes Group and related brands, including BionaireTM, Crock PotTM and HolmesTM.
- Advised SCA Hygiene Products AB, a global hygiene products manufacturer, in the acquisition of a Chinese manufacturer, including due diligence investigations of 34 facilities in 17 cities in China.
Joint Ventures
- Advised numerous multinational corporations on their joint ventures in China and Hong Kong, including Live Nation (formerly Clear Channel Entertainment), Stora Enso Oyj, Intelsat Ltd., San Miguel Brewing Ltd., General Motors Corporation, Samsung Electronics, LG Electronics, Scania AB, The Coca-Cola Company and NEC Corporation (in the largest Japanese investment in China).
Public-Private Partnerships
- Advised Hong Kong’s Mass Transit Railway Corporation in the structuring and documentation of two public-private partnership investments for mass transit rail lines and adjacent real estate development projects in Beijing and Shenzhen.
Restructuring and Enforcement
- Advised one of Korea’s largest chemical companies in the restructuring and disposition of a large-scale petrochemical facility in Shandong.
- Advised the “London Club” of more than sixty commercial banks in successive restructurings of four separate “jumbo loans” of more than $1.5 billion of U.S. dollar and yen denominated sovereign debt extended to the Republic of Indonesia.
Internal Investigations
- Represented the independent directors of The Minsheng Banking Corporation in an internal investigation of alleged fraudulent resolutions filed with a government regulatory agency.
- Represent foreign manufacturers and service providers regarding payments, gifts and reimbursements to government officials.
Banking and Bank Regulatory Matters
- Advised Construction Bank of China and Bank of China in investigating fraudulent investment and lending activities in various branches and the implementation of successful funds recovery programs.
- Advised a Swiss Bank on the merger of its two entities operating in China.
Intellectual Property
- Advised one of North America’s largest toy companies regarding its intellectual property (IP) rights protection program in China and Hong Kong, including pioneering initiatives to work with China’s customs officials to interdict, confiscate and destroy exports that infringed the client’s IP rights.
Arbitration
- Represented numerous companies before the China International Economic and Trade Arbitration Commission, including assisting a China joint venture in reversing an adverse award by CIETAC and obtaining substantial damages on its counterclaims.
|
Managing Partner, Asia
Michelle Taylor
+852 2218 9177
mtaylor@orrick.com
Senior Partner, Asia
Christopher Stephens
+852 2218 9111
cstephens@orrick.com
|